AURKB and neoplasm: In particular, Tozasertib, an Aurora kinase inhibitor, is hypothesized to interfere with the Aurora B phosphorylation of DNS1, thereby inhibiting the CENP-C:MIS12-C interaction and ultimately blocking mitosis and tumor proliferation 51,52.